-
Development of Two Versions of a Patient-Reported Outcome Measure to Evaluate Participant Experience and Satisfaction During the Intervention and Analytical Treatment Interruption Periods of Cure-Related and Other HIV Trials
Sep 9, 2025, 16:22 PM -
Managed Reimbursement of Continuous Glucose Monitoring Sensors in Ireland: Year One Review
Sep 9, 2025, 16:22 PM -
CAR-T Therapy in Asia-Pacific: Is It Reimbursed in Your Country?
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Atopic Dermatitis in Poland in Comparison With Efficacy Reported in Clinical Trials
Sep 9, 2025, 16:22 PM -
Generalizability of Patient Preference Study Results: A Weight and Test Approach
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Including X-linked Adrenoleukodystrophy in the Spanish Newborn Screening Program
Sep 9, 2025, 16:22 PM -
Embedding Patient Experience Data (PED) in EU Joint Clinical Assessments: Strategic Imperatives and Evidence Practices
Sep 9, 2025, 16:22 PM -
Economic Evaluation of the Adoption of Peritoneal Dialysis for Newly Diagnosed Hemodialysis Ineligible Pediatric End-Stage Kidney Disease Patients in Egypt
Sep 9, 2025, 16:22 PM -
Characteristics of Real-World Data Landscape in Italy: A Scoping Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Pharmacogenetic Testing to Guide Treatment for Children With Asthma
Sep 9, 2025, 16:22 PM -
Feasibility Assessment of an Indirect Treatment Comparison of Seladelpar vs. Elafibranor in Patients With Primary Biliary Cholangitis
Sep 9, 2025, 16:22 PM -
Middle East NICE Move Towards Standardized Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Clinical and Economic Impact of Hospital-Acquired Infections by Pseudomonas Aeruginosa in a Tertiary Care Teaching Hospital in India
Sep 9, 2025, 16:22 PM -
Therapeutic Potential of Bispecific Antibodies in Adenocarcinoma: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Medication Patterns of Traditional Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Faricimab vs. Aflibercept 8 mg in Patients With Neovascular Age-Related Macular Degeneration: A Cost-Utility Analysis in Italy
Sep 9, 2025, 16:22 PM -
Quantification of the HPV-Attributable Cancer Mortality in Greece: Years of Life Lost and Productivity Costs
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life in Patients With Mild Cognitive Impairment and Dementia and Their Caregivers in Thailand: A Cross-Sectional Study
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Subsequent Anticancer Therapy Use on Life-Year and QALY Estimates in Late-Line Metastatic Colorectal Cancer: A Health Economic Analysis of FRESCO-2
Sep 9, 2025, 16:22 PM -
Subtyping Atopic Dermatitis Trajectories Using Digital Patient-Reported Outcomes and Machine Learning
Sep 9, 2025, 16:22 PM
